53 SUPPLY CHAINS TO ADMIRE | 2023
53
In the industry, small companies outperform the larger players. Revenue growth is up 5%, and margins improved by 3% while inventory turns decreased by 6%. Table 37. Pharmaceuticals Sector Evaluation for the Period of 2013-2022
INDUSTRY: Pharmaceuticals
IMPROVE- MENT
COMPANY INFORMATION
PERFORMANCE
VALUE
RETURN ON INVESTED CAPITAL
2022 REVENUE (MS)
SUPPLY CHAIN INDEX
GROWTH (Year Over Year Revenue)
FUNDAMENTAL AVERAGE SCORE
INVENTORY TURNS
OPERATING MARGIN
PRICE TO BOOK
MARKET CAP
NAME
2013 - 2022
Abbott Laboratories
$43,653
8
9.1%
3.36
13.8%
8.0%
8
4.18
126,297
AbbVie Inc
$58,054
3
12.7%
4.30
31.0%
7.9%
6
18.00
152,114
AmerisourceBergen Corp
$238,587
1
12.1%
13.81
1.1%
7.6%
0
0.93
20,891
Amgen
$26,323
14
4.4%
1.45
38.0%
12.9%
9
11.62
122,845
Aspen Pharmacare Holdings Ltd
$2,535
23
3.9%
1.53
24.5%
6.8%
1
2.60
7,879
Astellas Pharma Inc
$11,546
18
-0.6%
2.04
15.1%
12.3%
9
2.40
28,428
AstraZeneca plc
$44,351
26
5.6%
1.97
9.7%
6.5%
7
6.07
115,531
Baxter International Inc.
$15,113
11
1.8%
3.56
9.1%
10.1%
9
3.77
30,770
Bayer
$53,509
16
1.0%
1.86
11.4%
6.0%
8
2.52
82,708
Biogen Idec Inc.
$10,173
16
7.4%
1.68
39.8%
21.1%
9
4.86
54,358
Biomarin Pharmaceutical Inc
$2,096
29
15.8%
0.58
-13.4%
-2.9%
6
5.62
15,220
Bristol-Myers Squibb Co.
$46,159
6
11.4%
4.00
16.7%
8.9%
9
5.42
114,944
Catalent Inc
$4,828
2
11.5%
5.24
13.4%
4.0%
6
4.25
7,688
Daiichi Sankyo Co Ltd
$9,308
15
-2.0%
2.00
9.8%
7.1%
8
2.73
30,499
Eli Lilly and Company
$28,541
12
2.7%
1.53
23.3%
18.7%
9
17.93
142,161
Gilead Sciences
$27,281
3
15.4%
3.62
48.6%
20.6%
9
5.73
102,259
GlaxoSmithKline
$36,313
30
-0.8%
1.81
19.7%
16.3%
6
54.27
83,035
Ipsen SA
$3,329
7
7.6%
2.49
23.2%
15.3%
NA
3.75
7,099
Johnson & Johnson
$94,943
25
3.6%
2.85
26.0%
15.6%
9
5.21
357,649
Merck and Company
$59,283
13
2.7%
2.65
19.6%
12.1%
9
5.12
181,588
Novartis AG
$51,828
28
0.1%
2.39
19.3%
12.1%
9
2.97
200,779
Novo Nordisk A/S
$25,085
20
6.5%
1.22
42.1%
68.2%
10
18.46
156,836
Perrigo Co PLC
$4,452
20
7.1%
3.01
11.4%
-1.4%
7
1.55
11,701
Pfizer, Inc.
$100,330
9
9.5%
1.84
26.0%
14.0%
9
3.19
221,762
Regeneron Pharmaceuticals Inc
$12,173
22
28.1%
1.29
38.0%
25.0%
8
8.18
48,637
Roche Holding
$66,351
24
2.3%
2.25
29.1%
22.9%
NA
9.63
256,639
Sanofi S.A.
$47,867
19
0.5%
1.56
21.1%
7.3%
8
1.72
118,863
Santen Pharmaceutical Co Ltd
$2,372
26
5.1%
2.75
18.9%
10.8%
9
2.64
5,998
Teva Pharmaceutical Industries Limited
$14,925
31
-2.8%
2.09
19.4%
-3.2%
6
1.28
25,565
United Therapeutics Corp
$1,936
3
8.2%
1.41
40.2%
19.6%
9
3.07
6,923
Zoetis Inc
$8,080
9
6.5%
1.25
29.3%
14.5%
9
19.34
48,954
MEAN WITH OUTLIERS
$37,139
6.3%
2.69
21.8%
13.0%
7.5
7.71
93,117
MEAN WITHOUT OUTLIERS
6.3%
2.32
21.8%
13.0%
7.5
6.16
93,117
Made with FlippingBook interactive PDF creator